Amrutanjan Health Care share news, announcements and annual reports
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹489.50.
28 Oct: open ₹492.70, high ₹500.20, low ₹488.30
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,425 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.41
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 21.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,23645.6% delivered
Amrutanjan Health Care has 504 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 27 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Amrutanjan Health Care quarterly results
The board meets on 3 Nov 2026 to consider financial results and dividend
Notice filed 27 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026 and dividend
Amrutanjan Health Care annual reports, presentations and earnings calls
The company's own documents, latest first.Amrutanjan Health Care financials, year by year
Annual reports12
- Annual report, year to Mar 20266 Oct 2026
- Annual report, year to Mar 20255 Sep 2025
- Annual report, year to Mar 202430 Aug 2024
- Annual report, year to Mar 202326 Aug 2023, a zip file
- Annual report, year to Mar 202226 Aug 2022, a zip file
7 earlier reports
- Annual report, year to Mar 202131 Aug 2021, a zip file
- Annual report, year to Mar 20201 Sep 2020, a zip file
- Annual report, year to Mar 20193 Sep 2019, a zip file
- Annual report, year to Mar 201818 Sep 2018, a zip file
- Annual report, year to Mar 201716 Oct 2017, a zip file
- Annual report, year to Mar 20166 Oct 2016, a zip file
- Annual report, year to Mar 20151 Sep 2015, a zip file
Investor presentations31
- Investor Presentation12 Aug 2026
- Investor Presentation9 May 2026
- Investor Presentation4 Feb 2026
- Investor Presentation11 Nov 2025
- Investor Presentation13 Aug 2025
26 earlier presentations
- Investor Presentation19 May 2025
- Investor Presentation14 Feb 2025
- Investor Presentation13 Nov 2024
- Investor Presentation14 Aug 2024
- Investor Presentation24 May 2024
- Investor Presentation10 Feb 2024
- Investor Presentation14 Nov 2023
- Investor Presentation4 Aug 2023
- Investor Presentation1 Jun 2023
- Investor Presentation14 Feb 2023
- Investor Presentation5 Nov 2022
- Investor Presentation18 Aug 2022
- Investor Presentation13 Aug 2022
- Investor Presentation25 May 2022
- Investor Presentation12 Feb 2022
- Investor Presentation9 Nov 2021
- Investor Presentation14 Aug 2021
- Investor Presentation27 May 2021
- Investor Presentation for quarter ended 31/12/202011 Feb 2021
- Investor Presentation for 30/09/202012 Nov 2020
- Investor Presentation for the quarter ended 30/06/202013 Aug 2020
- Investor Presentation for the quarter and year ended 31-03-202019 Jun 2020
- Investor presentation for the quarter ended 31-12-201912 Feb 2020
- Investor Presentation for the quarter ended 30.09.20197 Nov 2019
- Investor Presentation for the quarter ended 30-06-201913 Aug 2019
- Investor Presentation24 May 2019
Amrutanjan Health Care merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings2
- Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee) was approved by the National Company law Tribunal (NCLT) , Chennai vide their order dated July 13, 2017. E- form INC-28 has been filed with the Registrar of Companies on July 19, 2017.20 Jul 2017, a zip file
- Amrutanjan Health Care Limited has informed the regarding Modified Scheme of Amalgamation.17 Feb 2017, a zip file
Amrutanjan Health Care share news and announcements
Newest first. Page 1 of 11.
Oct 2026
9 Oct · Updates
Sep 2026
23 Sep · Meeting
Aug 2026
28 Aug · Updates
11 Aug · Corporate action
11 Aug · Results
6 Aug · Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015,
5 Aug · Board meeting
5 Aug · Rating
1 Aug · Legal
Jun 2026
19 Jun · General Updates
May 2026
27 May · Updates
26 May · Management
19 May · Meeting
18 May · Meeting
13 May · Updates
8 May · Results
Apr 2026
17 Apr · Business
17 Apr · Updates
Mar 2026
18 Mar · Legal
18 Mar · News Verification
The exchange asked on 17 Mar 2026
Feb 2026
3 Feb · Corporate action
3 Feb · Results
Jan 2026
Nov 2025
10 Nov · Corporate action
10 Nov · Results
Oct 2025
18 Oct · Legal
14 Oct · Business
Sep 2025
23 Sep · Meeting
15 Sep · Updates
5 Sep · Corrigendum
Aug 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 5 Aug 2026Credit ratingup 1.21%+1.0 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+3.1 pts vs Nifty 500) · volume 1.2× usual · delivery −4.5 pts against usual · The announcement
- 4 Feb 2026Resultsup 8.98%+8.6 pts vs Nifty 500market median −0.7% · five sessions +9.5% (+8.2 pts vs Nifty 500) · volume 3.2× usual · delivery −22.4 pts against usual · The announcement
- 11 Nov 2025Resultsup 2.60%+2.2 pts vs Nifty 500market median −0.7% · five sessions +1.2% (−0.4 pts vs Nifty 500) · volume 2.3× usual · delivery −28.7 pts against usual · The announcement
- 24 Sep 2025Board or managers changeddown 1.29%−0.7 pts vs Nifty 500market median 0.0% · five sessions −5.8% (−3.2 pts vs Nifty 500) · volume 0.6× usual · delivery −6.7 pts against usual · The announcement
- 13 Aug 2025Resultsup 2.16%+1.6 pts vs Nifty 500market median −0.7% · five sessions +7.7% (+5.1 pts vs Nifty 500) · volume 1.8× usual · delivery +2.0 pts against usual · The announcement
- 16 May 2025Dividenddown 1.92%−2.3 pts vs Nifty 500market median 0.0% · five sessions +0.9% (+1.7 pts vs Nifty 500) · volume 3.4× usual · delivery +25.3 pts against usual · The announcement
- 13 Feb 2025Dividendup 2.08%+2.1 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−1.6 pts vs Nifty 500) · volume 1.4× usual · delivery −16.0 pts against usual · The announcement
- 13 Nov 2024Dividendup 2.77%+4.6 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+8.1 pts vs Nifty 500) · volume 7.5× usual · delivery −28.1 pts against usual · The announcement
- 14 Aug 2024Resultsdown 2.81%−2.7 pts vs Nifty 500market median −0.7% · five sessions +3.5% (+0.6 pts vs Nifty 500) · volume 6.2× usual · delivery +3.1 pts against usual · The announcement
- 24 May 2024Dividenddown 4.08%−4.1 pts vs Nifty 500market median 0.0% · five sessions −6.3% (−4.2 pts vs Nifty 500) · volume 0.9× usual · delivery −8.9 pts against usual · The announcement
20 earlier announcements
- 12 Feb 2024Dividendup 7.79%+9.2 pts vs Nifty 500market median 0.0% · five sessions +12.1% (+11.1 pts vs Nifty 500) · volume 47.3× usual · delivery −36.1 pts against usual · The announcement
- 4 Aug 2023Buybackup 1.27%+0.6 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−2.7 pts vs Nifty 500) · volume 0.6× usual · delivery +13.4 pts against usual · The announcement
- 2 Aug 2023Buybackdown 0.12%+1.0 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−1.7 pts vs Nifty 500) · volume 1.3× usual · delivery +1.7 pts against usual · The announcement
- 4 Jul 2023Buybackup 1.21%+1.0 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+3.5 pts vs Nifty 500) · volume 0.6× usual · delivery −13.7 pts against usual · The announcement
- 31 May 2023Dividendup 0.42%+0.6 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−2.8 pts vs Nifty 500) · volume 1.4× usual · delivery −13.2 pts against usual · The announcement
- 15 Feb 2023Dividenddown 7.83%−8.3 pts vs Nifty 500market median 0.0% · five sessions −10.0% (−9.7 pts vs Nifty 500) · volume 5.7× usual · delivery −7.1 pts against usual · The announcement
- 7 Nov 2022Dividenddown 1.43%−2.0 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−1.9 pts vs Nifty 500) · volume 1.5× usual · delivery −5.2 pts against usual · The announcement
- 16 Aug 2022Resultsdown 9.73%−10.7 pts vs Nifty 500market median −0.7% · five sessions −11.3% (−10.4 pts vs Nifty 500) · volume 13.2× usual · delivery +10.7 pts against usual · The announcement
- 25 May 2022Dividenddown 4.29%−3.1 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−2.8 pts vs Nifty 500) · volume 1.2× usual · delivery +0.9 pts against usual · The announcement
- 11 Feb 2022Dividendup 0.58%+2.0 pts vs Nifty 500market median 0.0% · five sessions −4.0% (−1.8 pts vs Nifty 500) · volume 1.7× usual · delivery −18.0 pts against usual · The announcement
- 10 Nov 2021Dividenddown 4.16%−4.0 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−3.0 pts vs Nifty 500) · volume 1.0× usual · delivery −4.9 pts against usual · The announcement
- 16 Aug 2021Resultsup 4.78%+4.7 pts vs Nifty 500market median −0.7% · five sessions +0.9% (+1.9 pts vs Nifty 500) · volume 2.7× usual · delivery −10.8 pts against usual · The announcement
- 28 May 2021Dividenddown 7.86%−8.2 pts vs Nifty 500market median 0.0% · five sessions −8.6% (−11.0 pts vs Nifty 500) · volume 3.6× usual · delivery +5.9 pts against usual · The announcement
- 11 Feb 2021Dividendup 1.21%+0.7 pts vs Nifty 500market median 0.0% · five sessions +8.8% (+7.6 pts vs Nifty 500) · volume 7.7× usual · delivery −21.1 pts against usual · The announcement
- 12 Nov 2020Dividendup 11.68%+11.8 pts vs Nifty 500market median 0.0% · five sessions +17.2% (+15.0 pts vs Nifty 500) · volume 21.9× usual · delivery −27.0 pts against usual · The announcement
- 13 Aug 2020Resultsup 0.76%+0.5 pts vs Nifty 500market median −0.7% · five sessions −1.2% (−2.5 pts vs Nifty 500) · volume 3.4× usual · delivery −10.1 pts against usual · The announcement
- 18 Jun 2020Resultsup 2.80%+1.0 pts vs Nifty 500market median −0.7% · five sessions −3.5% (−7.8 pts vs Nifty 500) · volume 0.9× usual · delivery +3.7 pts against usual · The announcement
- 12 Feb 2020Dividendup 9.13%+8.6 pts vs Nifty 500market median 0.0% · five sessions +1.5% (+2.9 pts vs Nifty 500) · volume 7.8× usual · delivery −28.7 pts against usual · The announcement
- 7 Nov 2019Dividendup 5.95%+5.5 pts vs Nifty 500market median 0.0% · five sessions +1.4% (+2.1 pts vs Nifty 500) · volume 4.2× usual · delivery −20.7 pts against usual · The announcement
- 13 Aug 2019Resultsdown 3.01%−1.3 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−1.0 pts vs Nifty 500) · volume 3.2× usual · delivery +10.4 pts against usual · The announcement
Amrutanjan Health Care results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.